Corrections & Clarifications: A previous version of this story incorrectly described one of Jerry DeVries' surgeries. Jerry DeVries’ body is constantly changing on him. When he removes a custom molded ...

BURLINGTON, Mass.--(BUSINESS WIRE)--ArQule, Inc. (Nasdaq: ARQL), today announced that the first patient was dosed in the registrational MOSAIC (Miransertib in Overgrowth Syndromes in Adults and ...

Joseph Merrick had, by all accounts, a short and miserable life in which he was displayed as a carnival attraction called “The Elephant Man.” He was always a subject of medical curiosity, but the ...

ArQule, Inc. ARQL announced that the first patient for the phase I trial on oncology candidate, ARQ 092, for Proteus syndrome has been enrolled. The trial is being conducted by the National Human ...

A company sponsored phase 1/2 trial is being conducted in the U.S. and E.U. for Overgrowth Diseases, including PROS and Proteus syndrome. Miransertib is also in a phase 1 trial being conducted by the ...

The National Human Genome Research Institute (NHGRI), a branch of the NIH, has made an agreement with ArQule to support the clinical development of ARQ 092 for the rare disease Proteus syndrome. The ...

Proteus syndrome is a rare mosaic overgrowth disorder that is associated with severe complications. While anecdotal data have suggested that the life span of affected patients is reduced, this has not ...

A woman who had one of her 70-pound legs amputated claims the stump is growing, the Daily Mail reported. Mandy Sellars, 36, is suspected to suffer from a rare condition called Proteus syndrome, which ...